Olanzapine Plus Samidorphan in Subjects with Schizophrenia and Comorbid Alcohol Use Disorder: Rationale and Design for a Phase II, Double-blind, Randomized Study.
Background: Alcohol use disorder (AUD) is a common comorbidity in patients with schizophrenia. Although pharmacological options for the management of each disease exist separately, there is no agent approved for both. Moreover, studies conducted in this patient population, who face practical and soc...
| Publicado en: | Innovations in Clinical Neuroscience Vol. 16; no. 5/6; pp. 15 - 22 |
|---|---|
| Autores principales: | , , , , , , |
| Formato: | pictorial research tables/charts randomized controlled trial Journal Article |
| Publicado: |
Matrix Medical Communications, LLC
May/Jun2019
|
| Acceso en línea: | Ver este registro en EBSCOhost |